Personalis, Inc.

PSNL Healthcare Diagnostics & Research

Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

15.65 0.28 −1.76%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−10.5×
Dividend yield
—
F-score
4/9
Altman Z
3.35
Beneish M
−1.30
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
20.28 10.29 10.20 8.37
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(54.82) (29.53) (31.93) (26.52)
P/B ratio
6.01 2.61 2.72 3.37
Price to Tangible BV
6.01 2.61 2.72 3.37
EV/Sales
17.48 6.95 7.01 6.45
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(13.20) (5.64) (6.52) (7.37)
EV/FCF
(12.08) (5.31) (6.15) (6.74)
Quick Ratio
4.91 6.31 6.46 4.56
Current Ratio
5.28 6.61 6.76 4.82
Net Debt/EBITDA
6.60 7.54 10.15 6.91
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.24 0.22 0.23 0.29
Operating CF/Net income
0.81 0.75 0.93 1.01
Capex/Depreciation
(2.81) (2.47) (0.05) (1.07)
Interest Coverage
(907.86) (684.28) (388.71) (363.92)
Research and Development Expense of Revenue
73.07% 93.97% 75.36% 83.97%
Selling, General and Administrative Expense of Revenue
98.39% 115.71% 81.26% 89.92%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
17.81% 16.50% 13.25% 14.36%
Graham Net Nets
0.12 0.28 0.27 0.18
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(8.13%) (16.01%) (11.43%) (13.50%)
Free Cash Flow Yield
(7.14%) (12.74%) (11.18%) (11.44%)
Revenue per Share
0.21 0.15 0.19 0.16
Operating CF per Share
(0.24) (0.22) (0.25) (0.25)
Capex per Share
(0.04) (0.03) 0.00 (0.02)
Free Cash Flow per Share
(0.28) (0.25) (0.25) (0.26)
Cash per Share
2.02 2.24 2.69 1.70
Shareholders Equity per Share
2.23 2.45 2.93 1.93
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
2.23 2.45 2.93 1.93
Free Cash Flow
(29.55) (25.55) (22.32) (23.43)
Working Capital
198.67 219.15 228.32 138.25
Capital Expenditures
(3.78) (3.07) (0.08) (1.63)
Net Current Asset Value
168.08 187.57 194.97 102.98
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.17 0.20 0.00 0.11
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
12.53 12.00 12.17 13.93
Average Payables
12.97 10.30 9.69 11.80
Average Inventory
7.54 5.93 6.04 6.57
Average Assets
285.41 299.35 302.22 241.36
Average Common Equity
213.00 231.06 232.07 169.09

Fold the line items

Columns are period end dates